Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 350-354

  Chen, Yi Jen ^a,b   Chang, Jan Gowth ^a   Shih, Li Sun ^a   Chen, Pao Huei ^a   Endo, Mitsuo ^b   Whang Peng, Jacqueline ^c   Chen, Yi Ming A ^d  

^a JEN AI HOSPITAL   (Taiwan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030970326     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO;2-X     Document Type: Article

References (23)

1. BISHOP, J.M., Molecular themes in oncogenesis. Cell, 64, 235-248 (1991).
2. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., VENDER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
3. CAIRNS, P. and 20 OTHERS, Frequency of homozygous deletion at p16/ CDKN2 in primary human tumors. Nature Genet., 11, 210-212 (1995).
4. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAM, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the pI6 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32 (1994).
5. CORREA, P., A human model of gastric carcinogenesis. Cancer Res., 48, 3554-3560 (1988).
6. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all human cancers. Cancer Res., 55, 4525-1530 (1995).
7. HIRAMA, T. and KOEFFLER, H.P., Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854 (1995).
8. IGAKI, H., SASAKI, H., TACHIMORI, Y., KATO, H., WATANABE, H., KIMURA, T., HARADA, Y., SUGIMURA, T. and TERADA, M., Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423 (1995).
9. JEN, J., HARPER, J.W., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KINZLER, K.W. and VOGELSTEIN, B., Detection of p16 and p15 neues in brain tumors. Cancer Res., 54, 6353-6358 (1994).
10. KAMB, A., GRUIS, N.A., WEAVER, F.J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell-cycle regulator potentially involved in genesis of many tumor types. Science. 264, 436-440 (1994).
11. LAUREN, P., The two histological main types of gastric carcinoma, diffuse and so-called intestinal-type carcinoma. Acta pathol. microbiol. scand., 64, 31-49 (1965).
12. INk4A with human head-and-neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13, 561-568 (1996).
13. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692 (1995).
14. METTLIN, C., Epidemiologic studies in gastric adenocarcinoma. In: H.O. Douglass (ed.), Gastric cancer, pp. 1-25, Churchill-Livingstone, New York (1988).
15. MING, S.C., Gastric carcinoma, a pathobiological classification. Cancer, 39, 2475-2485 (1977).
16. MORI, T., MIURA, K., AOKI, T., HISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1/CDK41 (multiple tumor-suppressor/ cyclin-dependent kinase-4-inhibitor) gene in esophageal squamous-cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
17. NOBORI, T., MIURA, K., Wu, D.J., Lois, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
18. OHTA, M., INOUE, H., COTTICELLI, M.G., KASTURY, K., BAFFA, R., PALAZZO, J., SIPRASHVILI, Z., MORI, M., McCUE, P., DRUCK, T., CROCE, C.M. and HUEBNER, K., The FHITgene, spanning the chromosome 3p14.2 fragile site and renal-carcinoma-associated t(3:8) breakpoint, is abnormal in digestive- tract cancers. Cell, 84, 587-597 (1996).
19. SAKATA, K., TAMURA, G., MAESAWA, C., SUZUKI, Y., TERASHIMA, M., SATOH, K., DEA, Y., SUZUKI, A., SEKIYAMA, S. and SATODATE, R., Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas. Jap. J. Cancer Res., 86, 333-335 (1995).
20. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
21. SPRUCK, C.H.I., GONZALEZ-ZULUETA, M., SHIBATA, A., SIMONEAU, A.R., LIN, M.F., GONZALEZ, F., TSAI, Y.C. and JONES, P.A., p16 gene in uncultured tumors. Nature (Lond.) 370, 183-184 (1994).
22. STEPHEN, F.A., GISH, W., MILLER, W., MYERS, E.W. and LIPMAN, D.J., Basic local alignment search tool. J. mol. Biol., 215, 403-410 (1990).
23. TAHARA, E., Molecular mechanism of stomach carcinogenesis. J. Cancer Res. clin. Oncol, 119, 265-272 (1993).